Skip to main content
. 2014 Jun 6;1(1):e000020. doi: 10.1136/openhrt-2013-000020

Figure 1.

Figure 1

The CHA(2)DS2-(VASc) stroke risk and HAS-BLED bleeding risk index are calculated by totalling the scores for each risk factor present.68–71 The lower graph shows the expected stroke rate /100 patient (pt)-years, stratified by CHADS2 score in patients with AF not taking warfarin. Gage (2001): adjusted stroke rates/100 pt-years, assuming that aspirin was not taken68; Gage (2004): stroke rates/100 pt-years of aspirin69; Olesen (2011): event rates of hospital admission and death due to thromboembolism in patients with AF not taking warfarin.70 AF, atrial fibrillation; CHF, congestive heart failure; TIA, transient ischaemic attack; INR, international normalised ratio.